1. N-Pepstatinyl-N'-dinitrophenyl-1,6-diaminohexane, a potential active-site-directed localization reagent for cathepsin D, was found to bind non-specifically to immunoprecipitates containing cathepsin D. 2. Three new water-soluble localization reagents were synthesized, by using NN'-bis-(3-aminopropyl)piperazine, 3-oxa-1,5-diaminopentane or 3,6-dioxa-1,8-diamino-octane, as spacer arms between the pepstatin and dinitrophenyl moieties. 3. The hydrophilic dinitrophenyl-pepstatins were all tight-binding inhibitors of cathepsin D at pH3.5, but showed little or no binding to immunoprecipitates containing the inactive enzyme at pH 7.4. 4. Gel-chromatographic experiments showed that, at pH5.0, all the dinitrophenyl-pepstatins were bifunctional reagents able to bind cathepsin D and anti-dinitrophenyl antibody at the same time.
Enzyme-inhibitor-antibody complexes were not formed at pH 7.4, thus confirming that the reagents were active-site-directed. 5. Cultured human synovial cells were fixed and incubated with the dinitrophenyl-pepstatins at pH 5.0 or pH 7.4. After washing briefly, the cells were incubated at the appropriate pH value with anti-dinitrophenyl antibody labelled with fluorescein. When examined by fluorescence microscopy the cells stained at pH 5.0 showed fluorescent perinuclear granules, which were not seen in the cells treated at pH 7.4. The distribution of cathepsin D, determined by indirect immunofluorescence at pH 7.4, closely resembled that revealed by the dinitrophenyl-pepstatins at pH 5.0. 7. NN'-(3-Pepstatinylaminopropyl-3'-dinitrophenylaminopropyl)piperazine gave the most intense lysosomal staining and showed no non-specific binding. We conclude that this reagent is suitable for the subcellular localization of the active conformation of cathepsin D.
We have proposed (Knight et al., 1980 ) that tight-binding, or irreversible, active-site-directed inhibitors carrying reporter groups can be used to determine the subcellular location of proteinases that may be active under the conditions existing in living tissues. Briefly, the method employs an immunotrapping technique (Poole et al., 1973 (Poole et al., , 1974 to immobilize the proteinase as insoluble immune complexes at the sites of release in the living tissue.
These complexes are then treated in situ with the Abbreviations used: Dnp, dinitrophenyl; IgG, irnmunoglobulin G.
t To whom correspondence and requests for reprints should be sent. labelled inhibitor. Since active-site-directed inhibitors require the native enzyme structure for efficient interaction (Knight, 1977) , the binding of the inhibitor, assuming no non-specific interactions, demonstrates the presence of enzyme in the active conformation in the immune complex.
As a model system we studied the interactions between cathepsin D (EC 3.4.23.5 ) and derivatives of the tight-binding inhibitor pepstatin {N-[(3-methyl-1-oxobutyl)-L-valyl-L-valyl-(3S,4S)-4-amino-3-hydroxy-6-methylheptanoyl-L-alanyll-(3S,4S)-4-amino-3-hydroxy-6-methylheptanoic acid}. Pepstatin was modified to carry a dinitrophenyl (Dnp) group (Knight et al., 1980) , the photostable fluorophore bimane (Matthews et al., 1981a) or a biotin group (Matthews et al., 1981b) . in cultured human synovial cells (Matthews et al., 198 1a, b) .
Because the cathepsin D-pepstatin interaction is stoichiometric (Knight & Barrett, 1976) , it is probable that the subcellular location of the enzyme via the binding of a multiply labelled fluorescent protein will be a more sensitive method of detection than the direct localization of a fluorescent inhibitor. However, the pepstatin-biotin-avidin system (Matthews et al, 198 lb) may not always be suitable for the localization of cathepsin D, since avidin (pl 10.5) exhibits non-specific binding in cellular systems (Finn et al., 1980) and endogenous avidin-binding activity has been observed in tissues rich in biotin (Wood & Warnke, 1981) . In localization studies using labelled avidin, non-specific staining can be decreased, but not abolished, by chemical modification of the avidin lysine residues (Guesdon et al., 1979; Finn et al., 1980) , or, alternatively, by pretreatment of the tissue with unlabelled avidin and biotin (Wood & Warnke, 1981) .
We have suggested (Knight et al., 1980 ) that cathepsin D-bound Dnp-pepstatins can be located via the binding of high-affinity antibody to the Dnp group. In these antibody preparations most of the antibody species bind the hapten, N6-Dnp-lysine, with apparent dissociation constants less than 10-10M (cf. Knight & Green, 1976) . In contrast with avidin, such anti-Dnp antibody shows negligible non-specific binding to cultured human synovial cells. We report below the subcellular distribution of cathepsin D in these cells with Dnp-labelled pepstatins and a fluorescein-labelled antibody to Dnp.
Materials and methods
Pepstatin was from Protein Research Foundation, Osaka, Japan. N-Pepstatinyl-N'-2,4-dinitro-[3,5-3Hlphenyl-1,6-diaminohexane was made as described previously (Knight et al., 1980) . NN'-Bis(3-aminopropyl)piperazine and 3-oxa-1,5-diaminopentane dihydrochloride were from Aldrich Chemical Co., Gillingham, Dorset, U.K. 3,6-Dioxa-1,8-diamino-octane was kindly given by Professor J.-M. Lehn, Universite Louis Pasteur, Strasbourg, France. Benzotriazol-l-yloxytris(dimethylamino)-phosphonium hexafluorophosphate (Castro et aL, 1976) (Knight & Barrett, 1976 Diazomethane was prepared from N-methyl-Nnitroso-p-toluenesulphonamide (Vogel, 1956 ) and 3H-labelled by exchange with 3H20 at 0°C (Markey & Shaw, 1978) . 3H20 (0.2ml, 37GBq) was made alkaline with 5 M-NaOH (40A), and diazomethane in diethyl ether (2ml, approx. lOmg/ml) was added.
After 25 min at 0°C the ether phase was added to pepstatin (10mg, 14.5,umol) in dimethyl sulphoxide (0.3 ml) and allowed to react for 24 h. The solvents were removed in vacuo and pepstatin [3Himethyl ester was isolated by chromatography on Sephadex (Knight & Barrett, 1976 14.5,umol) was dissolved in dimethyl sulphoxide (0.3 ml) and dimethylformamide (0.25 ml) at 0°C. Triethylamine (2,ul, 14.4,umol) and isobutyl chloroformate (2,1, 15.4,umol) were added. After 25 min at 0°C, NN'-bis-(3-aminopropyl)piperazine (15,ul, 73,umol) was added and the reaction mixture was allowed to warm to 210C overnight. The solvents were removed in vacuo and NN'-(3-pepstatinylaminopropyl-3'-aminopropyl)piperazine was purified on Sephadex LH-20 and Bio-Rad AG50W-X2 resin (Knight & Barrett, 1976) . The product (yield: 2.3 mg, 18%) was homogeneous by t.l.c. on silica gel (RF 0.2; methanol/chloroform, 19: 1, v/v) . phenylaminopropyt)piperazine NN'-(3-Pepstatinylaminopropyl-3'-aminopropyl)-piperazine (2.3mg, 2.6,umol) in acmethyl sulphoxide (0.3 ml) was allowed to react in darkness with 1-fluoro-2,4-dinitro [3,5-3H] benzene (37 MBq, 0.042, umol) for 24h at 210C before addition of the unlabelled reagent (5,ul, 40,umol). After 24h the solvent was removed at 400C in vacuo. The residue was dissolved in ethanol (1 ml) and applied to a column (1 cm x 60cm) of Sephadex LH-20 and eluted with ethanol (12 ml/h). Fractions (1 ml) corresponding to the first yellow band eluted from the column were combined (8 ml) and evaporated. The residue was dissolved in ethanol (1 ml) and rechromatographed on Sephadex LH-20. The product from the second column was dissolved in methanol (0.25 ml) and applied to a silica-gel preparative-layer chromatography plate, which was developed with chloroform/methanol (9: 1, v/v). The major yellow band was scraped off and eluted with methanol (2 ml). After evaporation the product was freed from silica by dissolving in chloroform. NN'-(3-Pepstatinylaminopropyl-3'-[3 H]Dnp-aminopropyl)-piperazine (yield: 0.42mg, 15%) showed one component on t.l.c. on silica gel (RF 0.7; chloroform/methanol, 4: 1, v/v), which contained 97% of the radioactivity. The specific radioactivity of this product was 6.0MBq/umol. N-Pepstatinyl-N'-dinitro[3,5-3Hlphenyl-3-oxa-1,S- The specific radioactivity of this product was 6.0 MBq/,umol. N-Pepstatinyl-3,6-dioxa-1,8-diamino-octane 3, ul, 43, umol) and benzotriazol-1-yloxytris(dimethylamino)phosphonium hexafluorophosphate (19mg, 43,umol) were dissolved in dimethylformamide (1 ml) at 210C. Pepstatin (10mg, 14.5,umol) and triethylamine (8,1, 57,umol) were added and the mixture was stirred for 72h. After treatment with water (O.1ml) the solvent was filtered and evaporated to dryness. N-Pepstatinyl-3,6-dioxa-1,8-diamino-octane was purified on Sephadex LH-20 and Bio-Rad AG5OW-X2 resin (Knight & Barrett, 1976) . The product (yield: 3.5 mg, 29%) was homogeneous by t.l.c. on silica gel (RF 0.5, methanol) . N-pepstatinyl-3,6-dioxa-1,8-diamino-octane (1 mg, 1.22,umol) in dimethyl sulphoxide (0.1 ml) for 24h in darkness. 1-Fluoro-2,4-dinitrobenzene (5p1, 40pmol) was added and the mixture was left for a further 24h. The solvents were removed in vacuo and the residue was dissolved in ethanol (0.5 ml) and applied to a column (1 cm x 60 cm) of Sephadex LH-20 that was eluted with ethanol (12ml/h). A portion (1 1l) of each fraction (1 ml) was taken for the counting of radioactivity and a further portion (1ul) for the assay of cathepsin D inhibition (Knight & Barrett, 1976) . The leading inhibitory fractions that contained radioactivity were pooled (6 ml) and evaporated. The residue was dissolved in ethanol (0.5 ml) and rechromatographed on Sephadex LH-20. The leading fractions containing the radioactive inhibitor were combined (4 ml) and evaporated.
20,ug, 0.2%) showed one component on t.l.c. on silica gel (RF 0.85; chloroform/methanol, 9: 1, v/v), which contained 96% of the radioactivity. The specific radioactivity of this product was 4.1 MBq/pumol.
Anti-Dnp antibody
Fluorescein-labelled univalent (Fab) fragments of rabbit antibody to Dnp were prepared as described previously (Knight et al., 1980) . Bimane-labelled Fab fragments were also made (Matthews, 1982) and were shown by absorbance measurements at 280nm (McGuigan & Eisen, 1968) and 385nm (Kosower et al., 1979) (Ouchterlony, 1958) .
The tubes were left for 30min at 21 0C and then for 24h at 40C. After centrifugation at lOOOOg for 3 min the immunoprecipitates were washed twice by resuspension in the appropriate buffer (0.2 ml) and re-centrifugation. Experiments were done in duplicate in 0.05 M-sodium acetate/acetic acid, pH 5.0, and in 0.05 M-NaH2PO4/NaOH, pH 7.4. Both buffers contained 0.1M-NaCl and 0.1% Brij 35. The 3H-labelled pepstatin derivative (0.2ml, approx. IuM) was added to the immunoprecipitate and, after vigorous shaking, the mixture was left at 40C for 24 h with occasional shaking. After centrifugation at 1lOOOg for 3 min the precipitate was washed three times by resuspension in buffer (0.2 ml) for approx. 1 min and centrifugation. The final precipitate was dissolved in 30% (v/v) acetic acid (0.2ml) and a portion (0.1 ml) was taken for scintillation counting (Knight et al., 1980) .
Inhibition titrations
Cathepsin D activity was measured at 450C in 0.25M-sodium formate buffer, pH3.5, as described by Barrett (1970) . One unit of activity is defined as that producing an increase in absorbance (AA 28) of 1.0 in the assay during 60min under the specified conditions, a linear response being assumed. The assays were made in duplicate and were started by the addition of buffered haemoglobin to a mixture of cathepsin D (approx. 1 unit, 0.027 nmol/tube) and Dnp-pepstatin (0-0.04 nmol/tube). After 20min the trichloroacetic acid-soluble products of digestion of haemoglobin were measured by their A280. (Knight & Barrett, 1976; Matthews et al., 198 1a We observed previously (Knight et al., 1980 ) that N-pepstatinyl-N'-[3H]Dnp-1,6-diaminohexane behaved anomalously during chromatography on Sephadex G-100 at pH5.0, the radioactivity being eluted from the column at the position of serum albumin. The eluting buffer contained 0.1% Brij 35 to ensure recovery of cathepsin D activity from the column (Barrett, 1970) , and we concluded that the inhibitor was binding to detergent micelles. When a similar experiment was performed with N-pepstatinyl-N'-[3H]Dnp-3-oxa-1,5-diaminopentane, a rather broad band of radioactivity was eluted from the column, but the most radioactive fractions were found at the elution position of N6-Dnp-lysine hydrochloride. This experiment confirmed that nonspecific hydrophobic interactions were decreased by the use of a hydrophilic spacer arm.
Inhibition of cathepsin D by hydrophilic Dnppepstatins
The hydrophilic Dnp-pepstatins behaved like pepstatin and bound tightly and stoichiometrically to human cathepsin D at pH 3.5. The apparent dissociation constants, KD, were calculated from the deviation from stoichiometric inhibition in the region of the equivalence points (Green & Work, 1953; Knight & Barrett, 1976) . In each case the inhibitor concentration was assumed to be equal to that of the Dnp group and was calculated from the value of A344 in ethanol by using 6344 17 300 litre * mol-I*cm-l (the values for N6-Dnp-lysine hydantoin; cf. Knight et al., 1980) . The Dnp-pepstatins with NN'-bis-(3-aminopropyl)piperazine, 3-oxa-1,5-diaminopentane and 3,6-dioxa-1,8-diamino-octane spacer arms had KD values of 6.3 x 10-10M, 3.2 x 10-10M and 3.0 x 10-'0M respectively.
Gel chromatography of enzyme-inhibitor-antibody complexes on Ultragel AcA 44 Fluorescence-quenching studies (Knight et al., 1980) showed that, as expected for a low-molecularweight Dnp compound (Velick et al., 1960) , the Dnp group of N-pepstatinyl-N'-Dnp-1,6-diaminohexane was freely available to bind high-affinity antibody to Dnp. We have assumed that the hydrophilic Dnppepstatins behave similarly. However, the application of the Dnp-pepstatins to the localization of cathepsin D requires the Dnp-labelled inhibitors to Vol. 211 be bifunctional reagents, that is, to bind the proteinase and the antibody to Dnp simultaneously.
The formation of enzyme-inhibitor-antibody complexes by the Dnp-pepstatins at pH 5.0 was demonstrated by gel chromatography. Bimanelabelled univalent fragments (mol.wt. 45000) of antibody to Dnp (Matthews, 1982) and [3H]-Dnp-pepstatins were used. Human cathepsin D has mol.wt. 43000 and so that ternary complexes will have mol.wt. 89000 with associated radioactivity and fluorescence. When NN '-(3-pepstatinylamino- propyl-3'-[3H]Dnp-aminopropyl)piperazine was chromatographed on Ultragel AcA 44 at pH5.0 with an excess of cathepsin D and of bimane-labelled antibody fragments (Fig. la) the peak of radioactivity [a (partition coefficient) 0.251 was eluted before the antibody (a 0.39) and the cathepsin D activity (a 0.42). Moreover, the radioactive fractions contained some proteinase activity and a small peak of fluorescence, showing that the highmolecular-weight species was indeed the enzymeinhibitor-antibody complex.
A mixture of cathepsin D, 3H-labelled inhibitor and antibody fragments was also run on the column at pH 7.4. At this pH value no radioactive species of higher molecular weight was observed, and the radioactivity was eluted in the fractions containing the antibody (a 0.38). This behaviour was that expected if, like other pepstatin derivatives (Knight & Barrett, 1976; Matthews et al., 1981a) , NN'-(3 -pepstatinylaminopropyl-3'-[3HIDnp-aminopropyl)piperazine did not bind tightly to cathepsin D at the higher pH value.
Similar chromatographic experiments were performed with N-pepstatinyl-N'-[3H]Dnp-3-oxa-1,5-diaminopentane (Fig. 2) and N-pepstatinyl-N'-[3H]-Dnp-3,6-dioxa-1,8-diamino-octane (results not shown). In each case the ternary complex was observed at pH 5.0, but was not seen at pH 7.4. These experiments suggested that Dnp-pepstatins with hydrophilic spacer arms, used in conjunction with fluorescent anti-Dnp antibody, should be useful active-site-directed probes for the subcellular location of cathepsin D.
Subcellular location of cathepsin D in human synovial cells
When fixed human synovial cells were treated at pH 5.0 with NN'-(3-pepstatinylaminopropyl-3'-Dnpaminopropyl)piperazine and stained with fluorescein-labelled fragments of antibody to Dnp, a predominantly granular distribution of fluorescence was observed around the nuclei (Fig. 3a) . By marked contrast, no staining was seen when the labelling procedures were made at pH 7.4 (Fig. 3b) . Perinuclear granules were also revealed by fluorescent antibody to Dnp in cells treated at pH 5.0 with N-pepstatinyl-N' -Dnp-3 -oxa-1,5-diaminopentane ) and bimane-labelled fragments of antibody to Dnp (2.5 nmol) in elution buffer at pH 5.0. The mixture was left at 21 OC for 30min before being applied to the column. In (b) the same mixture of inhibitor, enzyme and antibody was prepared at pH 7.4 and was chromatographed at that pH value. Portions (0.1 ml) of each fraction were taken for the counting of radioactivity (M) and for the assay of cathepsin D activity (U). The remainder (0.7 ml) was taken for the measurement of bimane fluorescence (0). The arrows show the elution volumes of the following markers: 1, Blue Dextran 2000; 2, rabbit IgG (mol.wt. 150000); 3, avidin (68000); 4, cytochrome c (11700).
( Fig. 3c) and N-pepstatinyl-N'-Dnp-3,6-dioxa-1,8-diamino-octane (Fig. 3e) . These granules were not seen when the experiments were performed at pH 7.4 (Figs. 3d and 3f ). Univalent antibodies directed against human cathepsin D revealed a granular distribution of enzyme (Figs. 3g and 3h ) that was similar to that seen with the pepstatin probes. We concluded from these results that at pH 5.0 the Dnp-pepstatins were binding selectively to the active conformation of the lysosomal cathepsin D. Although lysosomal staining by fluorescent antiDnp antibody was observed at pH 5.0 with all the Dnp-pepstatins, the intensity of bound fluorescence was greatest with NN'-(3-pepstatinylaminopropyl-3'-Dnp-aminopropyl)piperazine. Moreover, this derivative stained the lysosomes with minimal non-specific binding (Figs. 3a and 3b) . By contrast, both N-pepstatinyl-N'-Dnp-3-oxa-1,5-diaminopentane and N-pepstatinyl-N'-Dnp-3,6-dioxa-1,8-diamino-octane stained the lysosomes less intensely, the former derivative being the least effective. In addition, each of these reagents produced some diffuse cytoplasmic fluorescence. Since this diffuse staining was present at both pH 5.0 (Figs. 3c and 3d ) and pH 7.4 (Figs. 3d and 3f ), the present observations suggest that these derivatives also bind somewhat non-specifically to human synovial cells.
Although staining pattern (compare Fig. 3g 
Discussion
In order to function as active-site-directed localization reagents for cathepsin D, Dnp-labelled pepstatins must bind only to the active enzyme and must also bind to fluorescent anti-Dnp antibody at the same time. We had shown (Knight et al., 1980) that to obtain such a bifunctional inhibitor it was necessary to separate the Dnp and pepstatin moieties by a chain of six carbon atoms. At shorter distances the binding was weakened by protein-protein interactions.
However, in the present study we found that the bifunctional reagent N-pepstatinyl-N'-Dnp-1,6-diaminohexane binds at pH 7.4 to immunoprecipitates containing inactive cathpesin D. Since pepstatin methyl ester did not bind under these conditions, it seemed probable that the hydrophobic nature of the Dnp-aminohexyl moiety (cf. Knight et al., 1980) was responsible for this non-specific interaction. We therefore synthesized some new Dnp-pepstatins with hydrophilic spacer arms and demonstrated that these derivatives had minimal non-specific interactions with immunoprecipitates.
The hydrophilic Dnp-pepstatins were all tightbinding inhibitors of cathepsin D at pH 3.5, with apparent dissociation-constant values of approx. 4 x 10-10m. These values were close to those obtained with pepstatin (Knight & Barrett, 1976) and the Dnp-aminoalkyl-pepstatins (Knight et al., 1980) . Previous work with N-pepstatinyl-diaminoethane (Knight & Barrett, 1976) had suggested that cationic derivatives of pepstatin were weaker inhibiVol. 211 I. T. W. Matthews, R. S. Decker, W. Hornebeck and C. G.-Knight 1983 tors of cathepsin D, but this was not the case with NN'-(3 -pepstatinylaminopropyl-3'-Dnp-aminopropyl)piperazine.
The interactions of the hydrophilic Dnp-pepstatins with cathepsin D and anti-Dnp Fab were characterized by gel-chromatographic studies with 3H-labelled inhibitors. In each case at pH5.0 the radioactivity was eluted from the column before the excess of proteinase and antibody, whereas at pH 7.4 the radioactivity was eluted in the fractions that contained the antibody (Figs. 1 and 2) . These results clearly demonstrated that the bifunctional nature of the Dnp-pepstatins was expressed only when the cathepsin D was in the native active conformation.
The elution characteristics of the ternary complexes at pH 5.0 were dependent on the length of the hydrophilic spacer arm. Thus the cathepsin D and anti-Dnp Fab associated with NN'-(3-pepstatinylaminopropyl-3' -[3HIDnp -aminopropyl)piperazine were eluted from the column clearly resolved from the excess of enzyme and antibody (Fig. la) . With N-pepstatinyl-N'-[ 3H IDnp-3 -oxa-1,5 -diaminopentane (Fig. 2a) , however, the radioactivity was eluted over a larger volume, and the associated enzyme and antibody were seen as shoulders on the leading edges of the main peaks. It is probable that this elution pattern reflects steric hindrance in the enzymeinhibitor-antibody complex. We demonstrated previously (Knight et al., 1980) , by using double immunodiffusion in agarose gels, that decreasing the chain length of the Dnp-aminoalkyl-pepstatins from six to four carbon atoms increased the dissociation of the ternary complex. The nitrogen atoms of the 3-oxa-1,5-diaminopentane spacer arm are separated by approx. 0.72nm, compared with 0.87nm for 1,6-diaminohexane and 0.62 nm for 1,4-diaminobutane.
A decrease in the stability of the ternary complex due to steric interactions between cathepsin D and anti-Dnp Fab fragment probably accounts for the much weaker staining of human synovial-cell lysosomes by N-pepstatinyl-N'-Dnp-3-oxa-1,5-diaminopentane (Fig. 3c) . For example, the binding of N-pepstatinyl -N' -biotinyl -1,2 -diaminoethane to cathepsin D (Matthews et al., 1981b) showed a marked dissociation in the presence of avidin, and the value of the apparent dissociation constant increased from 0.36nm to 2.3nM. This compound, when used in conjunction with tetramethylrhodamine-labelled avidin, failed to stain human synovial-cell lysosomes (Matthews et al., 1981 b) .
NN' -(3 -Pepstatinylaminopropyl -3'-Dnp -aminopropyl)piperazine was the most satisfactory localization reagent for the lysosomal cathepsin D. Bright staining of the enzyme was seen at pH 5.0 (Fig. 3a) , and little staining was seen at pH 7.4 (Fig. 3b) . N-Pepstatinyl-N'-Dnp-3,6-dioxa-1,8-diamino-octane gave less intense staining at pH 5.0 (Fig. 3e) , and non-specific staining was seen at pH 7.4 (Fig. 3f ). An additional disadvantage of the latter compound was the very poor synthetic yield.
In conclusion, NN'-(3-pepstatinylaminopropyl-3'-Dnp-aminopropyl)piperazine represents a significant improvement over our previous labelled pepstatin probes (Matthews et al., 198 1a, b) , for it gives a more intense fluorescent staining of the lysosomal cathepsin D with minimal non-specific staining.
